...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Broker Meeting 23 Feb
13
Feb 28, 2017 08:40PM
4
Feb 28, 2017 11:29PM
3
Mar 01, 2017 12:12AM
3
Mar 01, 2017 12:26AM
4
Mar 01, 2017 02:28AM
1
Mar 01, 2017 08:48AM
3
Mar 01, 2017 09:45AM
1
Mar 01, 2017 09:47AM
4
Mar 01, 2017 11:00AM
1
Mar 01, 2017 11:45AM
2
Mar 01, 2017 11:59AM
4
Mar 01, 2017 12:31PM
2
Mar 01, 2017 12:58PM
4
Mar 01, 2017 01:16PM
2
Mar 01, 2017 01:25PM
1
Mar 01, 2017 01:39PM

"58% Chance that this Phase 3 BETonMACE will be successful" and "64% probability of apabetalone sales for indications in the BETonMACE trial" arent' exactly the same thing. Split the difference and call it 61%. Either way, it's all a guessing game in my opinion until Q3/Q4 when we get past the futility analysis.

BearDownAZ

2
Mar 01, 2017 03:01PM
5
Mar 01, 2017 03:19PM
5
Mar 01, 2017 03:48PM

Mar 01, 2017 07:08PM
1
Mar 01, 2017 08:31PM
Share
New Message
Please login to post a reply